← Back to Clinical Trials
Recruiting NCT06671288

NCT06671288 "Effects of Balloon-blowing Exercises With Abdominal & Lumbar Core Muscle Activation Position Among Smokers"

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06671288
Status Recruiting
Phase
Sponsor Foundation University Islamabad
Condition Smoking
Study Type INTERVENTIONAL
Enrollment 21 participants
Start Date 2024-08-15
Primary Completion 2025-01-01

Eligibility & Interventions

Sex All sexes
Min Age 25 Years
Max Age 59 Years
Study Type INTERVENTIONAL
Interventions
Balloon-blowing exercises with abdominal & lumbar core muscle activation position.Diaphragmatic breathing exercise

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 21 participants in total. It began in 2024-08-15 with a primary completion date of 2025-01-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The principle function of the lungs is the facilitation of the gaseous exchange, commonly referred as respiratory or breathing. Cigarette smoking has detrimental effects on nearly every organ in the body, leading to a higher incidence of diseases and contributing to a gradual deterioration of the smoker's health.Cigarette smoking has detrimental effects on nearly every organ in the body, leading to a higher incidence of diseases and contributing to a gradual deterioration of the smoker's health. Cigarette smoking is linked to mild airway obstruction and a deceleration in the growth of lung function.Performing balloon-blowing exercises with abdominal and lumbar core muscles activation position leads to an improvement on pulmonary function and quality of life in smokers.

Eligibility Criteria

Inclusion Criteria: * Adults: aged (25-59 years) * Gender: Both males and females * Grade1- Grade 4 on Modified MRC dyspnea scale * COPD classes (mild, moderate ) according to GOLD COPD Guidelines * Participating voluntarily and follow the instructions \& performing * The number of packs of cigarettes smoked per day by the number of years the person has smoked. 1. pack yr = 20 cig/day x 1 yrs 2. pack yr = 20 cig/day x 2 yrs Exclusion criteria: * Severe cases of obstruction like Severe asthma \& status asthmaticus, Severe COPD, bullous emphysema for pneumothorax. * Any congenital deformities of chest wall, Demonstrated neuromuscular or neurological deficit/disease of chest wall * Other serious Cardiopulmonary diseases including pulmonary embolism, pulmonary ----Hypertension, Active TB, pneumonias or other acute illnesses * Any recent cardiothoracic or abdominal surgery, trauma or injury * Pregnancy * Any psychiatric illnesses

Contact & Investigator

Central Contact

Tooba Shahbaz, MS-CPT*

✉ tshahbaz59@gmail.com

📞 0340-5416747

Frequently Asked Questions

Who can join the NCT06671288 clinical trial?

This trial is open to participants of all sexes, aged 25 Years or older, up to 59 Years, studying Smoking. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06671288 currently recruiting?

Yes, NCT06671288 is actively recruiting participants. Contact the research team at tshahbaz59@gmail.com for enrollment information.

Where is the NCT06671288 trial being conducted?

This trial is being conducted at Rawalpindi, Pakistan.

Who is sponsoring the NCT06671288 clinical trial?

NCT06671288 is sponsored by Foundation University Islamabad. The trial plans to enroll 21 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology